Are there any conditions where nebulised adrenaline (adrenaline) is contraindicated for respiratory distress?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Nebulized adrenaline is contraindicated in patients with known hypersensitivity to epinephrine or its components, and caution is warranted in patients with cardiovascular disorders, including coronary artery disease, arrhythmias, or hypertension. When considering the use of nebulized adrenaline for respiratory distress, it is crucial to weigh the potential benefits against the risks, particularly in patients with certain underlying conditions.

  • Patients with a history of hypersensitivity to epinephrine or its components should not receive nebulized adrenaline due to the risk of an allergic reaction.
  • Caution is advised in patients with cardiovascular disease, as epinephrine can exacerbate conditions such as coronary artery disease, arrhythmias, or hypertension, as noted in a study discussing the therapeutic dilemmas of anaphylaxis in patients with cardiovascular disease 1.
  • Additionally, patients taking monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants should be treated with caution, as these medications can potentiate the effects of epinephrine, leading to severe hypertension.
  • Nebulized epinephrine is not the first-line treatment for asthma exacerbations; instead, beta-2 agonists like salbutamol are preferred.
  • The administration of nebulized epinephrine, typically in a 1:1000 solution (0.5 mL/kg up to 5 mL), requires monitoring for tachycardia, hypertension, and tremors.
  • The effects of nebulized epinephrine are temporary, lasting approximately 2-3 hours, which may necessitate repeated doses or additional interventions, particularly in conditions like croup or laryngeal edema, where it has been shown to be beneficial 2.
  • It's also important to consider the potential for other medications, such as ipratropium bromide and salbutamol, to increase intraocular pressure and cause acute angle-closure glaucoma in susceptible patients, although this is more directly related to these specific bronchodilators rather than adrenaline 3.
  • The use of epinephrine in anaphylaxis, including its administration via routes other than intramuscular injection, has been discussed, emphasizing its life-saving effects but also the need for careful consideration of its use in various clinical scenarios 4.

References

Research

Anaphylaxis and cardiovascular disease: therapeutic dilemmas.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2015

Research

[Acute angle-closure glaucoma resulting from treatment with nebulised bronchodilators].

Archivos de la Sociedad Espanola de Oftalmologia, 2006

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.